Oklahoma Alzheimer’s patients can help test new drug
Article in The Oklahoman by Susan Simpson - March 10, 2009
The web site for the study is http://www.icarastudy.com/
The drug is called Bapineuzumab, or Bapi. It is supposed to fight beta amyloid formation.
About 2,050 participants, 50 to 88, are being enrolled at some 200 sites across the US and Canada for the 83 week long study. Your patient has a 40% chance of getting a placebo. You have to attend 15 study events and have 6 infusions.